new position. After having watched Trinity Biotech, ticker TRIB , for nearly a year now (I previously posted on the firm last ..... pipeline of new products following a number of acquisitions by TRIB , the stock was overvalued given the execution risks involved
By Fredrik Arnold : Results from here , as verified using Yahoo Finance data for small, mid, & large cap healthcare sector stocks, as of market closing prices August 15 compared with analyst mean target price results one year hence showed Kindred Healthcare, Inc. (NYSE: KND ), flaunted a 30.33% ...
buying AZN ; pg 19]; Tullow Oil [TLW.uk; pg 20]; Irish small-cap medical testing equipment maker Trinity Biotech [ TRIB ; pg 40]. AIG story http://online.barrons.com/news/articles/SB50001424053111903409104579515680983549344?mod
150; pg 20]; global energy producer Hess [ HES ; pg 22]; medical testing equipment/instrument maker Trinity Biotech [ TRIB ; for diabetes at $25,000/device, Lyme disease, autoimmune disorders, herpes, syphilis, strep pneumonia, cardiac evaluation
spinoff from Kraft ( KFT ) whose new ticker will be KRFT ; pg 16); diabetes and other testing equipment maker Trinity Biotech ( TRIB ; pg 19); Steelcase ( SCS ; pg 20; see link below). SCS story http://online.barrons.com/article/SB50001424053111904414004578016383267957450